Assessing Psychosocial Burden in Psoriasis Patients Using the PRISM-RII Tool: A Comprehensive Evaluation
Keywords:
psoriasis, , psychodermatology, psychological impactAbstract
Introduction: Psoriasis is a chronic, immune-mediated inflammatory disease that significantly impacts patients' quality of life due to its visible lesions and associated stigma. Psychological comorbidities are prevalent among psoriasis patients.
Objectives: This study aimed to evaluate the utility of the Pictorial Representation of Illness and Self Measure Revised II (PRISM-RII) tool in assessing the psychosocial burden, including internalized stigma, in psoriasis patients.
Methods: A cross-sectional study was conducted with 190 psoriasis patients recruited from a university hospital's dermatology treatment center. Participants completed the PRISM-RII Psoriasis Internalized Stigma Scale (PISS), Hospital Anxiety and Depression Scale (HADS), and Dermatology Life Quality Index (DLQI). Clinical severity was measured using the Psoriasis Area and Severity Index (PASI).
Results: Significant correlations were observed between PRISM-RII parameters and measures of quality of life, internalized stigma, anxiety, and depression. Our study revealed significant differences in PASI scores among different Illness Perception Measures (IPM). A negative correlation was found between PASI and Self-Illness Separation (SIS), suggesting that increased disease severity is associated with a higher perceived burden of illness. Additionally, significant negative correlations were observed between SIS and DLQI, HADS, and PISS. Patients with larger IPM reported higher levels of anxiety, depression, and internalized stigma, as well as lower treatment satisfaction.
Conclusions: The PRISM-RII tool effectively captures the psychosocial burden of psoriasis including internalized stigmatization, highlighting the need to address both physical and psychological aspects in clinical practice. Incorporating PRISM-RII into routine assessments can enhance patient-centered care by identifying and addressing the psychosocial dimensions of psoriasis.
References
Zhang H, Yang Z, Tang K, Sun Q, Jin H. Stigmatization in patients with psoriasis: a mini review. Front Immunol. 2021;12:715839. DOI: 10.3389/fimmu.2021.715839. PMID: 34867945. PMCID: PMC8634029.
Ferreira BIRC, Da Costa Abreu JLP, Dos Reis JPG, Da Costa Figueiredo AM. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9(6):36-41. PMID: 27386050; PMCID: PMC4928455.
Alpsoy E, Babadag K, Karaman BF. Reliability and validity of internalized stigmatization scale in psoriasis. Turkderm-Arch of the Turkish Dermatol and Venerol 2015;49(1):45-9. DOI: 10.4274/turkderm.54521
Alpsoy E, Polat M, Fettahlıoglu-Karaman B, et al. Internalized stigma in psoriasis: a multicenter study. J Dermatol. 2017;44(8):885-91. DOI: 10.1111/1346-8138.13841. PMID: 28407292.
Corrigan PW, Druss BG, Perlick DA. The impact of mental illness stigma on seeking and participating in mental health care. Psychol Sci Public Interest. 2014;15(2):37-70. DOI: 10.1177/1529100614531398. PMID: 26171956.
Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984-91. DOI: 10.1038/jid.2014.530. PMID: 25521458; PMCID: PMC4378256.
Innamorati M, Quinto RM, Lester D, et al. Cognitive impairment in patients with psoriasis: a matched case-control study. J Psychosom Res. 2018;105:99-105. DOI: 10.1016/j.jpsychores.2017.12.011. PMID: 29332640.
Zink A, Herrmann M, Fischer T, et al. Addiction: an underestimated problem in psoriasis health care. J Eur Acad Dermatol Venereol. 2017;31(8):1308-15. DOI: 10.1111/jdv.14204. PMID: 28281329.
Łakuta P, Przybyła-Basista H. Toward a better understanding of social anxiety and depression in psoriasis patients: the role of determinants, mediators, and moderators. J Psychosom Res. 2017;94:32-8. DOI: 10.1016/j.jpsychores.2017.01.007. PMID: 28183400.
Büchi S, Buddeberg C, Klaghofer R, et al. Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) - a brief method to assess suffering. Psychother Psychosom. 2002;71(6):333-41. DOI: 10.1159/000065994. PMID: 12411768.
Mühleisen B, Büchi S, Schmidhauser S, et al. Pictorial Representation of Illness and Self Measure (PRISM): a novel visual instrument to measure quality of life in dermatological inpatients. Arch Dermatol. 2009;145(7):774-80. DOI: 10.1001/archdermatol.2009.121. PMID: 19620558.
Büchi S, Sensky T, Sharpe L, Timberlake N. Graphic representation of illness: a novel method of measuring patients’ perceptions of the impact of illness. Psychother Psychosom. 1998;67(4-5):222-5. DOI: 10.1159/000012284. PMID: 9693349.
Wouters E, Reimus J, Van Nunen A, et al. Suffering quantified? Feasibility and psychometric characteristics of 2 revised versions of the Pictorial Representation of Illness and Self Measure (PRISM). Behav Med. 2008;34(2):65-78. DOI: 10.3200/BMED.34.2.65-78. PMID: 18682339.
Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121(1):31-49. DOI: 10.1016/j.psychres.2003.08.008. PMID: 14572622.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. PMID: 6880820.
Aydemir Ö, Güvenir T, Küey L, Kültür S. Reliability and validity of the Turkish version of Hospital Anxiety and Depression Scale. Turk Psikiyatri Dergisi. 1997;8:280-7.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. PMID: 8033378.
Öztürkcan S, Ermertcan AT, Eser E, Turhan Şahin M. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45(11):1300-7. DOI: 10.1111/j.1365-4632.2006.02881.x. PMID: 17076710.
Fotiou K, Hofmann M, Kaufmann R, Thaci D. Pictorial representation of illness and self measure (PRISM): an effective tool to assess the burden of psoriasis. J Eur Acad Dermatol Venereol. 2015;29(12):2356-62. DOI: 10.1111/jdv.13232. PMID: 26332649.
Grob JJ. Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? J Invest Dermatol. 2007;127(9):2299-301. DOI: 10.1038/sj.jid.5701081. PMID: 17853918.
Nijsten T, Meads DM, De Korte J, et al. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol. 2007;127(9):2315-22. DOI: 10.1038/sj.jid.5700875. PMID: 17495953.
Niedermann K, de Bie RA, Kubli R, et al. Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis: a randomized controlled trial. Patient Educ Couns. 2011;82:42-8. DOI: 10.1016/j.pec.2010.02.014. PMID: 20451345.
Büchi S, Brändli O, Klingler K, Klaghofer R, Buddeberg C. Inpatient rehabilitation in inpatients with chronic obstructive lung diseases (COPD): effect on physical capacity for work, psychological wellbeing and quality of life. Schweiz Med Wochenschr. 2000;130(5):135-42. PMID: 10701230.
Buchi S, Villiger P, Kauer Y, et al. PRISM (Pictorial Representation of Illness and Self Measure)- a novel visual method to assess the global burden of illness in patients with systemic lupus erythematosus. Lupus. 2000;9(5):368-73. DOI: 10.1191/096120300678828479. PMID: 10878730.
Kassardjian CD, Gardner-Nix J, Dupak K, et al. Validating PRISM (Pictorial Representation of Illness and Self Measure) as a measure of suffering in chronic non-cancer pain patients. J Pain. 2008;9(12):1135-43. DOI: 10.1016/j.jpain.2008.06.016. PMID: 18755635.
Rumpf HJ, Löntz W, Uesseler S. A self-administered version of a brief measure of suffering: first aspects of validity. Psychother Psychosom. 2004;73(1):53-6. DOI: 10.1159/000074440. PMID: 14665796.
Töndury B, Büchi S, Kauer Y, Schärer L, Villiger PM. The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria. J Investig Allergol Clin Immunol. 2011;21(2):93-100. PMID: 21462798.
Reimus JLM, Vingerhoets AJJM, Soons PHGM, Korstanje MJ. Suffering in psoriasis patients: its relation with illness severity and subjective well-being. Int J Dermatol. 2007;46(10):1042-5. DOI: 10.1111/j.1365-4632.2007.03191.x. PMID: 17910711.
Corazza M, Flacco ME, Schettini N, Borghi A. Suffering and quality of life impairment in patients with eczematous diseases: results from an observational study assessing the relevance of the involvement of two sensitive body sites, namely, the face and hands. Dermatology. 2023;239(4):368-78. DOI: 10.1159/000528822. PMID: 36642071.
Min C, Kim M, Oh DJ, Choi HG. Bidirectional association between psoriasis and depression: two longitudinal follow-up studies using a national sample cohort. J Affect Disord. 2020;262:126-32. DOI: 10.1016/j.jad.2019.10.043. PMID: 31733456.
Mizara A, Papadopoulos L, McBride SR. Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease. Br J Dermatol. 2012;166(5):986-93. DOI: 10.1111/j.1365-2133.2011.10799.x. PMID: 22211355.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Elif Afacan Yıldırım, Muhterem Polat , Yusuf Ezel Yıldırım

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.